T-NBOMe
Tryptamine-NBOMe
N-(2-Methoxybenzyl)tryptamine
 
2-(1H-Indol-3-yl)-N-[(2-methoxyphenyl)methyl]ethan-1-amine
2-(1H-Indol-3-yl)-N-(2-methoxybenzyl)ethan-1-amine
 5566 ·  C18H20N2O ·  280.364
 InChI=1S/C18H20N2O/c1-21-18-9-5-2-6-15(18)12-19-11-10-14-13-20-17-8-4-3-7-16(14)17/h2-9,13,19-20H,10-12H2,1H3
 HJCSKFSDXDPIKM-UHFFFAOYSA-N This stereoisomer Any stereoisomer
 COc1ccccc1CNCCc1c[nH]c2c1cccc2

Heim, R. Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl partial structure. SC. D. Thesis, Freie Universität, Berlin, 1 Jan 2004. 3.9 MB. In German.

Silva, ME; Heim, R; Strasser, A; Elz, S; Dove, S. Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor. J. Comput. Aided Mol. Des., 1 Jan 2011, 25 (1), 51–66. 834 kB. https://doi.org/10.1007/s10822-010-9400-2

Silva, ME. Theoretical study of the interaction of agonists with the 5-HT2A receptor. Ph. D. Thesis, Universität Regensburg, Regensburg, Germany, 26 Aug 2008. 5.9 MB.

Hyperlab. Hyperlab new compounds. 29 Sep 2014. 232 kB. Note: Contains links to hyperlab.info that require elevated access/karma to follow.

Heim, R; Pertz, HH; Elz, S. Preparation and in-vitro pharmacology of novel secondary amine-type 5-HT2A-receptor agonists: From submillimolar to subnanomolar activity. Arch. Pharm. Pharm. Med. Chem., Mar 1999, 331 (Suppl. 1), 34. 493 kB. #3 Poster abstract

5MT-NB
5-BnO-NMT
5840
5829
5828
4-BzO-AMT
5806
13 November 2018 · Creative Commons BY-NC-SA ·